EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Successful Sequential Multimodal Therapy for Lingual Rhabdomyosarcoma in a Young Adult: Case Report

Jonathan Villanueva Dominguez, Josué Vázquez Arizmendi iD, Vianey Guadalupe Saldaña Herrera iD, Ivan Meneses Morales iD, Gabriel Ernesto Díaz Juarez iD, Carlos Enrique Arciniega Vega, Rowena Lopez Chávez iD, Azucena Ocampo Bárcenas iD

Case Reports in Oncological Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/crom/7742907 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Oncological Medicine, online erschienen am 21.07.2026. Verfasst von Jonathan Villanueva Dominguez und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Cancer Institute "Dr. Arturo Beltrán Ortega", Acapulco, Guerrero, Mexico. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lingual rhabdomyosarcoma (RMS) in adults is an exceedingly rare malignancy, with very few cases reported and no standardized treatment guidelines. We present the case of a 19‐year‐old male diagnosed with lingual RMS who underwent sequential multimodal therapy. The patient initially received doxorubicin combined with ifosfamide chemotherapy followed by cisplatin combined with 5‐fluorouracil, both of which resulted in disease progression. A third‐line regimen with vincristine, actinomycin D, and cyclophosphamide (VAC) together with pembrolizumab achieved only transient stabilization and was limited by toxicity. Subsequent treatment with cetuximab together with bevacizumab induced a significant partial response with acceptable tolerance, which was consolidated with intensity‐modulated radiotherapy (IMRT) to the primary site and cervical lymph nodes. Surveillance imaging confirmed durable locoregional control without evidence of systemic disease, whereas swallowing and phonation were preserved. This case illustrates the value of individualized stepwise management in adult RMS and suggests that the integration of immunotherapy and antiangiogenic therapy may provide meaningful tumor control and functional preservation in selected patients.

Schlagwörter

Stichwörter der Autor:innen

adult rhabdomyosarcomaantiangiogenic therapyhead and neck sarcomaimmunotherapylingual rhabdomyosarcoma

Autor:innen und Institutionen

  • State Cancer Institute "Dr. Arturo Beltrán Ortega", Acapulco, Guerrero, Mexico.
  • Center for Research on Tropical Diseases, Autonomous University of Guerrero, Acapulco, Guerrero, Mexico, uagro.mx.
  • Faculty of Chemical Sciences, Juárez University of the State of Durango, Durango, Durango, Mexico.

ORCID-Profile: Josué Vázquez Arizmendi, Vianey Guadalupe Saldaña Herrera, Ivan Meneses Morales, Gabriel Ernesto Díaz Juarez, Rowena Lopez Chávez, Azucena Ocampo Bárcenas

Zitieren

APA

Dominguez, J. V., Arizmendi, J. V., Herrera, V. G. S., Morales, I. M., Juarez, G. E. D., Vega, C. E. A., Chávez, R. L., & Bárcenas, A. O. (2026). Successful Sequential Multimodal Therapy for Lingual Rhabdomyosarcoma in a Young Adult: Case Report. Case Reports in Oncological Medicine, 2026(1). https://doi.org/10.1155/crom/7742907

Vancouver

Dominguez JV, Arizmendi JV, Herrera VGS, Morales IM, Juarez GED, Vega CEA, et al. Successful Sequential Multimodal Therapy for Lingual Rhabdomyosarcoma in a Young Adult: Case Report. Case Reports in Oncological Medicine. 2026;2026(1). doi:10.1155/crom/7742907

BibTeX
@article{Dominguez2026,
  author = {Dominguez, Jonathan Villanueva and Arizmendi, Josué Vázquez and Herrera, Vianey Guadalupe Saldaña and Morales, Ivan Meneses and Juarez, Gabriel Ernesto Díaz and Vega, Carlos Enrique Arciniega and Chávez, Rowena Lopez and Bárcenas, Azucena Ocampo},
  title = {Successful Sequential Multimodal Therapy for Lingual Rhabdomyosarcoma in a Young Adult: Case Report},
  journal = {Case Reports in Oncological Medicine},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crom/7742907}
}
Kostenlos starten →